论文部分内容阅读
目的研究阿奇霉素与特步他林雾化吸入治疗小儿支原体肺炎的临床效果及安全性。方法 60例支原体肺炎患儿,随机分为试验组与参照组,各30例。试验组给予阿奇霉素与特步他林雾化吸入治疗,参照组给予红霉素与小儿咳喘灵口服液治疗。观察两组的治疗效果及不良反应。结果试验组的总有效率93.33%显著高于参照组73.33%,试验组的退热时间、咳嗽及肺部啰音消失时间均要明显少于参照组,不良反应发生率也低于参照组,两组比较差异有统计学意义(P<0.05)。结论阿奇霉素与特步他林雾化吸入治疗小儿支原体肺炎,可有效缓解患儿的临床症状,疗效显著。
Objective To study the clinical effects and safety of azithromycin and Xteparin in the treatment of mycoplasma pneumonia in children. Methods Sixty children with mycoplasmal pneumonia were randomly divided into test group and reference group, with 30 cases in each group. The experimental group was treated with azithromycin and Xteptaralin, and the reference group was given erythromycin and pediatric Kechuanling oral liquid. Observation of the two groups of treatment and adverse reactions. Results The total effective rate was 93.33% in the experimental group was significantly higher than the reference group 73.33%, the experimental group of antipyretic time, cough and pulmonary rales disappear time were significantly less than the reference group, the incidence of adverse reactions is also lower than the reference group, The difference between the two groups was statistically significant (P <0.05). Conclusion Azithromycin and tebutrine inhalation treatment of children with mycoplasma pneumonia, can effectively alleviate the clinical symptoms of children with significant effect.